Mitochondrial oxidative stress and the metabolic syndrome

Trends in Endocrinology and Metabolism

Volumn 23, Issue 9, 2012, Pages 429-434

  James, Andrew M ^a   Collins, Yvonne ^a   Logan, Angela ^a   Murphy, Michael P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRUVATE DEHYDROGENASE KINASE 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CITRIC ACID CYCLE; DISEASE COURSE; FEEDBACK SYSTEM; GENOTYPE; IMMOBILIZATION; METABOLIC REGULATION; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUTRIENT SUPPLY; OVERNUTRITION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; METABOLIC SYNDROME X; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84865438468     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.06.008     Document Type: Article

References (60)

1. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
2. Whaley-Connell A., et al. The role of oxidative stress in the metabolic syndrome. Rev. Cardiovasc. Med. 2011, 12:21-29.
3. Alemany M. Utilization of dietary glucose in the metabolic syndrome. Nutr. Metab. 2011, 8:74.
4. Thyfault J.P., Krogh-Madsen R. Metabolic disruptions induced by reduced ambulatory activity in free-living humans. J. Appl. Physiol. 2011, 111:1218-1224.
5. Watanabe S., et al. Liver diseases and metabolic syndrome. J. Gastroenterol. 2008, 43:509-518.
6. Reaven G.M. The metabolic syndrome: time to get off the merry-go-round?. J. Intern. Med. 2011, 269:127-136.
7. Randle P.J. Metabolic fuel selection: general integration at the whole-body level. Proc. Nutr. Soc. 1995, 54:317-327.
8. Parker V.E.R., et al. Mechanistic insights into insulin resistance in the genetic era. Diabet. Med. 2011, 28:1476-1486.
9. Coll A.P., et al. The hormonal control of food intake. Cell 2007, 129:251-262.
10. Henriksen E.J., et al. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 2011, 51:993-999.
11. Houstis N., et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
12. Bonnard C., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 2008, 118:789-800.
13. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 2009, 119:573-581.
14. Hoehn K.L., et al. Insulin resistance is a cellular antioxidant defense mechanism. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17787-17792.
15. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
16. Martins A.R., et al. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis. 2012, 11:30.
17. Balaban R.S., et al. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
18. Finkel T. Radical medicine: treating ageing to cure disease. Nat. Rev. Mol. Cell Biol. 2005, 6:971-976.
19. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148:1145-1159.
20. Wallace D.C., et al. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 2010, 5:297-348.
21. Duchen M.R., Szabadkai G. Roles of mitochondria in human disease. Essays Biochem. 2010, 47:115-137.
22. Saraste M. Oxidative phosphorylation at the fin de siècle. Science 1999, 283:1488-1493.
23. Brand M.D., Murphy M.P. Control of electron flux through the respiratory chain in mitochondria and cells. Biol. Rev. 1987, 62:141-193.
24. Brown G.C. Control of respiration and ATP synthesis in mamalian mitochondria and cells. Biochem. J. 1992, 284:1-13.
25. Joseph J.W., et al. The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J. Biol. Chem. 2006, 281:35624-35632.
26. Harper J.A., et al. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes. Rev. 2001, 2:255-265.
27. Cheng Z., et al. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol. Metab. 2010, 21:589-598.
28. Chance B., et al. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979, 59:527-605.
29. Winterbourn C.C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 2008, 4:278-287.
30. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 1994, 269:29405-29408.
31. Sawyer D.T., Velentine J.S. How super is superoxide?. Acc. Chem. Res. 1981, 14:393-400.
32. •-), superoxide dismutases, and related matters. J. Biol. Chem. 1997, 272:18515-18517.
33. Wispe J.R., et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J. Biol. Chem. 1992, 267:23937-23941.
34. Forman H.J., Azzi A. On the virtual existence of superoxide anions in mitochondria: thoughts regarding its role in pathophysiology. FASEB J. 1997, 11:374-375.
35. Cox A.G., et al. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 2010, 425:313-325.
36. Collins Y., et al. Mitochondrial redox signalling at a glance. J. Cell Sci. 2012, 125:801-806.
37. -/- mice. Free Radic. Biol. Med. 2012, 52:841-849.
38. Rodriguez-Cuenca S., et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic. Biol. Med. 2010, 48:161-172.
39. Han D.H., et al. Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance. PLoS ONE 2011, 6:e19739.
40. Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194:7-15.
41. Janssen-Heininger Y.M., et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 2008, 45:1-17.
42. Murphy M.P., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab. 2011, 13:361-366.
43. 2, a necessary evil for cell signaling. Science 2006, 312:1882-1883.
44. 2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab. 2011, 13:340-350.
45. Weisiger R.A., Fridovich I. Superoxide dismutase. Organelle specificity. J. Biol. Chem. 1973, 248:3582-3592.
46. Zhou L., et al. A reaction-diffusion model of ROS-induced ROS release in a mitochondrial network. PLoS Comput. Biol. 2010, 6:e1000657.
47. Li Y., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking mamganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
48. Melov S., et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:846-851.
49. Melov S., et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998, 18:159-163.
50. Chen Z., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 1998, 30:2281-2289.
51. Gardner P.R., et al. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12248-12252.
52. Gardner P.R. Aconitase: sensitive target and measure of superoxide. Methods Enzymol. 2002, 349:9-23.
53. Yan L.-J., et al. Oxidative damage during ageing targets mitochondrial aconitase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11168-11172.
54. Cochemé H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J. Biol. Chem. 2008, 283:1786-1798.
55. Lee P.E., et al. DNA-mediated redox signaling for transcriptional activation of SoxR. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13164-13168.
56. Nedergaard J., Cannon B. The 'novel' 'uncoupling' proteins UCP2 and UCP3: what do they really do? Pros and cons for suggested functions. Exp. Physiol. 2003, 88:65-84.
57. Rhee S.G., et al. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000, 2000:pe1.
58. Pletjushkina O.Y., et al. Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion. Cell Death Differ. 2005, 12:1442-1444.
59. Hurd T.R., et al. Detection of reactive oxygen species-sensitive thiol proteins by redox difference gel electrophoresis: implications for mitochondrial redox signaling. J. Biol. Chem. 2007, 282:22040-22051.
60. Roche T.E., Hiromasa Y. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell. Mol. Life Sci. 2007, 64:830-849.